Monday, 18 Jun 2018

You are here

Risk of Paternal Exposure to Anti-Rheumatic Drugs

Seminars in Arthritis and Rheumatism features a review of the effects of paternal use of antirheumatic drugs on pregnancy, specifically addressing the effects of NSAIDs, steroids, DMARDs and biologics on spermatogenesis and the effect on pregnancy outcomes and offspring.

There is limited data regarding paternal exposure to arthritis medications, and less counseling of would-be fathers about the fetal effects of their medications.  This review discusses the approach and provides a compendium of data in text and table form on what is currently known, as digested by authorities in this area. 

There are several take-home messages from this report:

1. Many of our current limitations are due to a lack of robust data regarding paternal exposure with individual drugs.

2. Many antirheumatic medications can be continued in men who want to father a child.

3. Regular pre-conceptional counseling should be given to male patients of fertile age as an integral part of family planning.

4. It is erroneous to extrapolate from the female pregnancy experience when counseling their male partners.

Examples of drug effect on Spermatogenesis and Counseling Recommendations include:  

DrugSpermatogenesisMale Counseling
NSAIDSNot fully investigated no link between paternal drug exposure and adverse pregnancy outcomes
SteroidsLimited data; no correlation with infertility in menNo harmful effects have emerged for low (<10 mg prednisone/day) doses.
MTXStudies showed alterations in sperm DNA after MTX exposure Some believe it is ok to maintain MTX therapy in men throughout the disease course to avoid unnecessary flares, as controlled studies have not shown increased malformation rates with male exposure
SSZOligospermia, reduced mobility and increase of pathologic sperm morphology Stop SSZ 3 months before conception 
MMFLimited data; but no effect on sperm in rat studies MMF is a known, clear teratogen in women. But 3 studies in men have failed to show any increase risk of malformations with male use of MMF.
AZANo impairment No increased risk of congenital abnormalities in offspring of fathers treated with thiopurines and male fertility not affected
 TNF inhibitors No impairment TNFi do not influence male fertility or harm offspring. Risks are the same as female exposure and thus should be continued to avoid flare (if needed)
Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Could Measuring Drug Levels with TNF Treatment Hurt Your Patients?

Our colleagues in gastroenterology measure drug levels with certain biologics used in inflammatory bowel disease in order to increase the dose for optimal benefit if the patient has a low trough level (i.e. targeting drug level).

There have been GI trials with T2T with drug levels but they are not always suggesting that the strategy is superior to usual care. Also, this is really not a common practice in rheumatology.

Methotrexate Update

I was delighted to see that investigators presenting work at EULAR 2018 haven’t lost interest in our old friend methotrexate, with a number of abstracts examining issues of safety, dose and route of administration.

Low incidence of methotrexate induced liver abnormalities

Cancer Therapies Inducing Immune-Related Adverse Events (irAEs)

Recent shifts in the cancer treatment paradigm towards immune therapies has led to wide implementation of the novel immune check point inhibitors (ICI) in the treatment of multiple types of advanced cancer.

While being quite effective in oncology, these checkpoint inhibitors have led to the emergence of a quite unique spectrum of rheumatologic conditions presented under the umbrella of immune-related adverse events (irAEs).

Tobacco Associated Deaths in the USA

JAMA Internal Medicine reports that in the USA, those who smoke cigar, pipe, or cigarette have a significant overall  mortality risk, and a much highers cancer mortality risk compared to nonsmokers.

The National Longitudinal Mortality Study collected baseline survey data from 1985 through 2011 and included 357,420 participants reporting on their use of cigar, pipes, or cigarettes.

MMWR: Cannabis Use in the Colorado Workers

MMWR reports that eight states, including Colorado, have legalized recreational marijuana for use by adults and that a study of use in Colorado has shown that nearly 15% of Colorado adult workers have used marijuana in the past 30 days. Use was highest among young adults, especially men, working in the Accommodation/Food Services and Food Preparation/Serving industries.